Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

Menarini supports the EFPIA campaign: We Won't Rest

Disease never takes a break, so neither do we. We won't rest until people around the world see a brighter tomorrow.

AMR: Let's find the solution

Menarini supports the EFPIA campaign 'We Won't Rest'

#WeWontRest until we make the impossible, possible

Menarini - EFPIA Innovation Campaign

We Won't Rest until there is a COVID-19 vaccine for everyone

Menarini and EFPIA together in fighting COVID-19

EFPIA COVID-19 priorities

Illness never sleeps #WeWontRest

#WeWontRest for a Brighter Tomorrow

A lifetime of breakthroughs

For The Chance To...

newsletter

Subscribe to the newsletter

Subscribe to the newsletter to be updated on Menarini news.

Media Contact

Media Contact

To access the service it is necessary to declare to have read the privacy information.